Chemokines and their receptors in lung cancer progression and metastasis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Zhejiang University SCIENCE B

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1631/jzus.B1500258PMID 27143261PMCID PMC4868824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling

  2015cited by this paper
• The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.

  2014cited by this paper
• CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis

  2014cited by this paper
• Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer.

  2014cited by this paper
• [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].

  2014cited by this paper
• Thromboxane A2 receptor‐mediated release of matrix metalloproteinase‐1 (MMP‐1) induces expression of monocyte chemoattractant protein‐1 (MCP‐1) by activation of protease‐activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells

  2014cited by this paper
• Effect of CXCL12/CXCR4 on increasing the metastatic potential of non-small cell lung cancer in vitro is inhibited through the downregulation of CXCR4 chemokine receptor expression

  2014cited by this paper
• High-level C-X-C chemokine receptor type 4 expression correlates with brain-specific metastasis following complete resection of non-small cell lung cancer

  2014cited by this paper
• Lung cancer chemoprevention: current status and future prospects

  2013cited by this paper
• Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.

  2013cited by this paper
• The liberated domain I of urokinase plasminogen activator receptor – a new tumour marker in small cell lung cancer

  2013cited by this paper
• The Involvement of NRF2 in Lung Cancer

  2013cited by this paper
• Chemokines in tumor progression and metastasis

  2013cited by this paper
• The Ubiquitin–CXCR4 Axis Plays an Important Role in Acute Lung Infection–Enhanced Lung Tumor Metastasis

  2013cited by this paper
• C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1

  2013cited by this paper
• High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients

  2013cited by this paper
• Activation of Thromboxane A2 Receptor (TP) Increases the Expression of Monocyte Chemoattractant Protein -1 (MCP-1)/Chemokine (C-C motif) Ligand 2 (CCL2) and Recruits Macrophages to Promote Invasion of Lung Cancer Cells

  2013cited by this paper
• CCL19/CCR7 upregulates heparanase via specificity protein-1 (Sp1) to promote invasion of cell in lung cancer

  2013cited by this paper
• Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase

  2013cited by this paper
• Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines

  2013cited by this paper
• CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

  2013cited by this paper
• CCL21 Chemokine Therapy for Lung Cancer.

  2013cited by this paper
• Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance

  2013cited by this paper
• Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

  2013cited by this paper
• CCL2 is critical for immunosuppression to promote cancer metastasis

  2012cited by this paper
• Cancer treatment and survivorship statistics, 2012

  2012cited by this paper
• Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Chemokines in tumor development and progression.

  2012cited by this paper
• Development of novel CXCR4-based therapeutics

  2012cited by this paper
• Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model.

  2012cited by this paper
• Recent advances in non-small cell lung cancer biology and clinical management.

  2012cited by this paper
• Chemokines as mediators of tumor angiogenesis and neovascularization.

  2011cited by this paper
• Potential of CXCR4 antagonists for the treatment of metastatic lung cancer

  2011cited by this paper
• Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.

  2011cited by this paper
• The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor

  2011cited by this paper
• Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Extracellular ubiquitin: immune modulator and endogenous opponent of damage‐associated molecular pattern molecules

  2011cited by this paper
• Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.

  2011cited by this paper
• CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.

  2011cited by this paper
• Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.

  2010cited by this paper
• Cell of origin of lung cancer

  2010cited by this paper
• CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin*

  2010cited by this paper
• CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

  2010cited by this paper
• The chemokine system in cancer biology and therapy.

  2010cited by this paper
• CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

  2009cited by this paper
• Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival

  2009cited by this paper
• Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma

  2009cited by this paper
• Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.

  2008cited by this paper
• Identification and expansion of the tumorigenic lung cancer stem cell population

  2008cited by this paper
• Evolving role of uPA/uPAR system in human cancers.

  2008cited by this paper
• Chemokine signaling via the CXCR2 receptor reinforces senescence.

  2008cited by this paper
• Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis

  2008cited by this paper
• Urokinase Plasminogen Activator Receptor Choreographs Multiple Ligand Interactions: Implications for Tumor Progression and Therapy

  2008cited by this paper
• Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer.

  2007cited by this paper
• Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation

  2007cited by this paper
• HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Antitumour activity of cationic‐liposome‐conjugated adenovirus containing the CCL19 [chemokine (C‐C motif) ligand 19] gene

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.

  2007cited by this paper
• High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.

  2006cited by this paper
• Role of CCL25/CCR9 in immune homeostasis and disease

  2006cited by this paper
• Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.

  2006cited by this paper
• CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

  2006cited by this paper
• Growth regulated oncogene is pivotal in thrombin-induced angiogenesis.

  2006cited by this paper
• Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α*

  2005cited by this paper
• Estimates of cancer incidence in China for 2000 and projections for 2005.

  2005cited by this paper
• Differential Expression of CXCR4 Is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells

  2005cited by this paper
• Chemokines in tumor progression and metastasis

  2005cited by this paper
• [Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China].

  2005cited by this paper
• Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

  2005cited by this paper
• CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.

  2005cited by this paper
• IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis1

  2005cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper
• Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion

  2004cited by this paper
• The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell lung cancer metastases.

  2004cited by this paper
• The significance of cancer cell expression of the chemokine receptor CXCR4.

  2004cited by this paper
• CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A1

  2004cited by this paper
• Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis

  2004cited by this paper
• EBV-Induced Molecule 1 Ligand Chemokine (ELC/CCL19) Promotes IFN-γ-Dependent Antitumor Responses in a Lung Cancer Model

  2003cited by this paper
• Regulation of the Chemokine Receptor CXCR4 by Hypoxia

  2003cited by this paper
• Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma.

  2003cited by this paper
• The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

  2003cited by this paper
• NF-κB, chemokine gene transcription and tumour growth

  2002cited by this paper
• Nf-kappa B, chemokine gene transcription and tumour growth.

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Chemokines: a new classification system and their role in immunity.

  2000cited by this paper
• Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

  1998cited by this paper
• Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.

  1994cited by this paper
• Structure—function relationships in the receptor for urokinase‐type plasminogen activator Comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins

  1994cited by this paper
• Cancer statistics

  1989cited by this paper
• Molecular Sciences Vascular Endothelial Growth Factor Induces Cxcl1 Chemokine Release via Jnk and Pi-3k-dependent Pathways in Human Lung Carcinoma Epithelial Cells

  year unknowncited by this paper

• Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review

  2025cites this paper
• Fungi and cancer: unveiling the complex role of fungal infections in tumor biology and therapeutic resistance

  2025cites this paper
• Identification of hub genes between moderate to severe asthma and early lung adenocarcinoma through bioinformatics analysis

  2025cites this paper
• Level and clinical significance of serum CXC chemokine ligand 13 in patients with hepatocellular carcinoma

  2025cites this paper
• Multiplexed Molecular Endophenotypes Help Identify Hub Genes in Non-Small Cell Lung Cancer: Unlocking Next-Generation Cancer Phenomics

  2025cites this paper
• Key genes associated with brain metastasis in non-small cell lung cancer: novel insights from bioinformatics analysis

  2025cites this paper
• Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect

  2025cites this paper
• The multifaceted role of SOX2 in breast and lung cancer dynamics.

  2024cites this paper
• SDF-1 promotes metastasis of NSCLC by enhancing chemoattraction of megakaryocytes through the PI3K/Akt signaling pathway

  2024cites this paper
• Burn Pit Smoke Condensate-Mediated Toxicity in Human Airway Epithelial Cells.

  2024cites this paper
• Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants

  2024cites this paper
• Small cell lung cancer co-culture organoids provide insights into cancer cell survival after chemotherapy

  2023cites this paper
• Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

  2023cites this paper
• Identifying New Contributors to Brain Metastasis in Lung Adenocarcinoma: A Transcriptomic Meta-Analysis

  2023cites this paper
• Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy

  2023cites this paper
• CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC).

  2023cites this paper
• CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer.

  2022cites this paper
• Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I–III lung squamous cell carcinoma

  2022cites this paper
• Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer

  2022cites this paper
• The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer

  2022cites this paper
• Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome.

  2021cites this paper
• Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer

  2021cites this paper
• CCL24 Protects Renal Function by Controlling Inflammation in Podocytes

  2021cites this paper
• Chemokines: CC Family☆

  2021cites this paper
• Quercetin Inhibits the Epithelial to Mesenchymal Transition through Suppressing Akt Mediated Nuclear Translocation of β-Catenin in Lung Cancer Cell Line

  2021cites this paper
• GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner.

  2021cites this paper
• A seven-gene signature and the C–C motif chemokine receptor family genes are the sarcoma-related immune genes

  2021cites this paper
• Rethinking the Chemokine Cascade in Brain Metastasis: Preventive and Therapeutic Implications.

  2021cites this paper
• The prediction of survival and analysis of microenvironment in patients with sarcoma

  2020cites this paper
• Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis

  2020cites this paper
• Correlation between CXCR5 expression and prognosis in stage T1 non-small cell lung cancer

  2020cites this paper
• Correlation between CXCR4, CXCR5 and CCR7 expression and survival outcomes in patients with clinical T1N0M0 non‐small cell lung cancer

  2020cites this paper
• Initial neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with inoperable locally advanced non-small-cell lung cancer.

  2020cites this paper
• The role of CXCL chemokine family in the development and progression of gastric cancer.

  2020cites this paper
• UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway

  2019cites this paper
• An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer

  2019cites this paper
• Candidate genes and pathways associated with brain metastasis from lung cancer compared with lymph node metastasis

  2019cites this paper
• CXCL13/CXCR5 signaling axis in cancer.

  2019cites this paper
• IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446

  2018cites this paper
• Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach

  2018cites this paper
• Bushenshugan Formula Attenuates the Development of Lung Cancer by Inhibiting Epithelial-Mesenchymal Transition

  2018cites this paper
• Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment

  2018cites this paper
• Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis

  2017cites this paper
• A tail-based test for differential expression analysis and pathway analysis in RNA-sequencing data

  2017cites this paper
• Integration Of Mutation And Gene Expression Data To Identify Disease Subtypes

  2017cites this paper
• The Role of Atypical Chemokine Receptor CCXCKR (CCRL1) in Human Diseases

  2016cites this paper
• Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.

  2016cites this paper
• CXCL13-CXCR5 axis(cid:0)regulation in in�ammatory diseases and cancer

  year unknowncites this paper